MARKET

TLGT

TLGT

Teligent Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.6211
-0.0089
-1.41%
Closed 16:00 11/15 EST
OPEN
0.6353
PREV CLOSE
0.6300
HIGH
0.6353
LOW
0.6150
VOLUME
100.25K
TURNOVER
--
52 WEEK HIGH
2.855
52 WEEK LOW
0.4170
MARKET CAP
33.45M
P/E (TTM)
-0.9767
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of TLGT and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 4 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

TLGT News

  • Teligent, Inc. to Present at Jefferies Global Healthcare Conference in London on Wednesday November 20, 2019
  • GlobeNewswire.3d ago
  • Edited Transcript of TLGT earnings conference call or presentation 4-Nov-19 9:30pm GMT
  • Thomson Reuters StreetEvents.11/09 16:55
  • Teligent EPS misses by $0.02, misses on revenue
  • seekingalpha.11/05 02:20
  • Teligent, Inc. (TLGT) CEO Jason Grenfell-Gardner on Q3 2019 Results - Earnings Call Transcript
  • Seeking Alpha - Transcript.11/05 00:08

More

Industry

Pharmaceuticals
+1.37%
Pharmaceuticals & Medical Research
+1.34%

Hot Stocks

Name
Price
%Change

About TLGT

Teligent, Inc. is a specialty generic pharmaceutical company. Under the Company's own label, it markets and sells generic injectable pharmaceutical products in the United States and Canada. In the United States it marketed 16 generic topical pharmaceutical products and four branded generic pharmaceutical products, as of December 31, 2016. It provides development, formulation and manufacturing services to the pharmaceutical, over-the-counter (OTC) and cosmetic industries. It focuses on developing, manufacturing and marketing a portfolio of generic pharmaceutical products under its own label in topical, injectable, complex and ophthalmic dosage forms, and managing its contract manufacturing and formulation services business. Its pipeline included 34 Abbreviated New Drug Application(ANDAs) filed with the United States Food and Drug Administration (FDA) for additional pharmaceutical products, as of December 31, 2016.
More

Webull offers Teligent Inc (TLGT) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.